• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COPAN FLOCK TECHNOLOGIES SRL FLOQSWAB; APPLICATOR, ABORBENT TIPPED, STERILE, PRODUCT CODE: KXG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COPAN FLOCK TECHNOLOGIES SRL FLOQSWAB; APPLICATOR, ABORBENT TIPPED, STERILE, PRODUCT CODE: KXG Back to Search Results
Model Number 503CS01
Device Problems Break (1069); Entrapment of Device (1212); Appropriate Term/Code Not Available (3191)
Patient Problem No Code Available (3191)
Event Date 04/22/2019
Event Type  malfunction  
Manufacturer Narrative
Copan checked the device history records related to the manufacturing and controls before the release on the market of the reported product 503cs01, lot number 1816965 ( (b)(4) pieces).No anomalies have been found.No other incidents on the same lot have been reported.The involved device was not available to be returned to copan for evaluation.Mechanical swab shaft bending tests (according to release sop) have been performed on the retained samples of the reported lot on the point where the breakage occured, in order to test shaft resistance to breakage.All the swabs subjected to the bending tests gave conforming results.Following the receipt of the filled questionnaire, additional clarifications/information have been requested.The internal investigation is still in progress.A follow-up report will be sent.
 
Event Description
The event occurred in (b)(6).On (b)(6) 2019 copan became aware that a swab broke during a sample collection.The information was received by email from a (b)(4) distributor.The email stated that the broken part of the swab was removed with endoscope.On (b)(6) 2019, copan sent a questionnaire to the distributor in order to acquire more information on patient's health and on the event for the internal investigation.On (b)(6) 2019 copan received the questionnaire completed with information provided by the manager of diagnostic test department.The following details have been reported: the swab was used for a nasopharyngeal collection to detect influenza infection.No pre-collection steps were performed.The patient was sedated and collaborative during the sampling.No sign of damage was visible on the swab before the use.The swab broke at the first diameter change.Since the broken part was not immediately found, on the same day of the event, additional tests were performed at otorhinolaryngology hospital and a ct and endoscopy were performed.The broken piece was discharged by feces the day after the incident, not removed by endoscope as initially informed.Since the patient felt emotional anxiety, he needed psychotherapy treatment.
 
Event Description
This is a follow-up report for a case of swab broken during specimen collection occurred in korea (initial report # 3005477219-2019-00003).This incident was the second of three incidents occurred in korea between (b)(6) 2019 and (b)(6) 2019 for a swab (product code #503cs01) broken during nasopharyngeal collection.Notification was received by the same korean distributor.Copan submitted an mdr report as manufacturer (# 3005477219-2019-00002, # 3005477219-2019-00003, # 3005477219-2019-00004) for each of these events.Copan found out that the involved swab #503cs01 (released on the market by copan as a single product) was a component of the kit standard q influenza a/b for the influenza virus a type and b type antigens detection made by sd biosensor inc.On 31st july, copan became aware that the sd biosensor's kit standard q influenza a/b is not sold on us market.
 
Manufacturer Narrative
The internal investigation reported with the initial mdr is confirmed.In addition, copan investigated this incident considering the information received for the 3 events to determine if a root cause was attributable to the use of the swab as a component of the sd biosensor's kit.Copan checked the content of the ifu of standard q influenza a/b kit that include instructions for nasopharyngeal collection using the swab.The ifu's kit showed no misalignment with the content of copan's instructions for sample collection.A further evaluation was performed taking into consideration the packaging of standard q influenza a/b.The kit includes #25 pieces of swab #503cs01.The kit packaging (inclusion of copan swabs into standard q influenza a/b) is performed by the sd biosensor inc.Using an internal sd biosensor sop.This sop was not shared with copan so no consideration on the packaging process was possible.On july 3rd, 2019 copan received a sample of the sd biosensor's standard q influenza a/b kit for internal evaluation (the lot of the kit was not one of those involved in the incidents).The internal investigation could not identify a root cause related to the use of the swab #503cs01 with standard q influenza a/b; however, we cannot exclude that the reprocessing activities (packaging of the kit) performed by sd biosensor inc may have contributed to the incidents.An analysis of the incidence of the problem has been performed from 2014 up to date.Copan received 19 worldwide complaints related to breakage of swab during sampling collection procedure for product containing the same type of swab #503cs01.Comparing the number of these complaints with the number of pieces sold worldwide from 2014 to 2018: the failure incidence (floqswabs 503cs01 breakage during sampling) is (b)(4).Considering that it was not possible to establish a correlation between the use of the swab into sd biosensor kit and these incidents, that the swab breakage has been already considered as hazard in the product risk analysis, that to our knowledge no event has led to serious medical consequences so far in similar circumstances (breakage of the swab during collection) and that the incidence rate is very rare, no corrective actions is planned at this time.Copan will continue to monitor products for similar events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLOQSWAB
Type of Device
APPLICATOR, ABORBENT TIPPED, STERILE, PRODUCT CODE: KXG
Manufacturer (Section D)
COPAN FLOCK TECHNOLOGIES SRL
via f. perotti 16-18
brescia, 25125
IT  25125
MDR Report Key8644180
MDR Text Key146489029
Report Number3005477219-2019-00003
Device Sequence Number1
Product Code KXG
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Type of Report Initial,Followup
Report Date 04/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/27/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date07/31/2021
Device Model Number503CS01
Device Catalogue Number503CS01
Device Lot Number1812449
Was Device Available for Evaluation? No
Date Manufacturer Received04/29/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-